Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 406 AL 420

Medicinal chemistry approaches for dual inhibition of amyloid-β and tau aggregation in Alzheimer's disease

Jangra J, Mahindru I, Kumar A, Gupta HK, Ramesh VK, Kumar R.

Future Med Chem. 2026 Apr;18(8):961-978. doi: 10.1080/17568919.2026.2636501. Epub 2026 Mar 2.

Natural Products for Alzheimer's Disease: A New Twist Impacting Ferroptosis

Yi Y, Jia P, Xie P, Peng X, Zhu X, Yin S, Yan C, Yu G.

Am J Chin Med. 2026;54(3):707-731. doi: 10.1142/S0192415X26500266. Epub 2026 Apr 30.

Harmine and its derivatives: A promising multi-target therapeutic avenue for Alzheimer's disease

Shen X, Dong X, Nao J.

Neuroscience. 2026 May 7;601:155-168. doi: 10.1016/j.neuroscience.2026.03.006. Epub 2026 Mar 9.

A Systematic Review to Evaluate the Effect of Neflamapimod on Cognitive Function and Progression of Dementia

Tyagi S, Murali N, Singh SK, Babtiwale SR, Padhi BK, Lakshmi NRA, Gandhi AP.

Neurol India. 2026 Jan 1;74(1):12-19. doi: 10.4103/neurol-india.Neurol-India-D-25-00227. Epub 2026 Jan 9.

The corporate takeover of Alzheimer's treatment: a crisis in neurological autonomy?

Araujo AQC.

Arq Neuropsiquiatr. 2026 Mar;84(3):1-5. doi: 10.1055/s-0046-1817020. Epub 2026 Mar 11.

Targeting mitochondrial quality control in Alzheimer's disease: Mechanisms and therapeutic potential of phytomedicines

Lin Z, Zhang S, Sun M.

Pharmacol Res. 2026 Jun;228:108202. doi: 10.1016/j.phrs.2026.108202. Epub 2026 Apr 21.

Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery

Al Khzem AH, Gomaa MS.

Drug Des Devel Ther. 2026 Apr 13;20:597087. doi: 10.2147/DDDT.S597087. eCollection 2026.

From pathology to precision therapy: Contemporary and emerging strategies in Alzheimer's disease treatment

Belavadi S, Kadiri SK.

Eur J Pharmacol. 2026 May 28;1025:178913. doi: 10.1016/j.ejphar.2026.178913. Epub 2026 Apr 29.

Understanding the contribution of toxicant exposures to Alzheimer's disease and related dementias

Howell GR, Territo PR, Aylor D, Goldstein LE.

Curr Opin Neurobiol. 2026 Jun;98:103192. doi: 10.1016/j.conb.2026.103192. Epub 2026 Apr 9.

Neuropeptides in the Management of Alzheimer's Disease: From Pathophysiology to Therapeutic Opportunities

Tiwari S, Yadav SK, Kumari M, Dhakal T, Puranik N.

Int J Mol Sci. 2026 Apr 1;27(7):3206. doi: 10.3390/ijms27073206.

Crosstalk between death-associated protein kinase 1-regulated mechanisms and dysfunctions in alzheimer's disease

Shukla S, Singh RK.

Mol Biol Rep. 2026 May 22;53(1):799. doi: 10.1007/s11033-026-11933-5.

Inhaled General Anesthetics in Alzheimer's Disease Progression: Divergent Effects, Underlying Mechanisms, and Future Perspectives

Yang L, Song G, Parker E, Yang L.

Mol Neurobiol. 2026 Mar 31;63(1):542. doi: 10.1007/s12035-026-05832-w.

Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease

Vijverberg EGB, Scharre DW, Woodward M, Catalano S, Hamby ME, Grundman M, Morgan RE, Iaci J, Devins T, Caggiano AO.

J Alzheimers Dis. 2026 May;111(2):897-908. doi: 10.1177/13872877261437145. Epub 2026 Apr 3.

Safety profiles of lecanemab: A systematic review and meta-analysis of randomized controlled trials and real-world evidence

Qi L, Zheng F, Tu M, Abdullah R, Zhao Y, Su X, Zhou D, Peng G.

J Prev Alzheimers Dis. 2026 Mar;13(3):100473. doi: 10.1016/j.tjpad.2025.100473. Epub 2026 Jan 1.

Advances in the drug treatment of Alzheimer's disease: pathophysiology and mechanisms of action

Nowell J, Crook H, de Leon MJ, Edison P.

BMJ. 2026 Apr 20;393:78881. doi: 10.1136/bmj-2023-078881.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias